SEC Filing Summary: National Health Investors Inc. (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors Inc. on May 5, 2025. The filing serves as a Regulation FD disclosure to disseminate an investor presentation and a press release titled "NHI Issues Investor Update" to the public. The company is incorporated in Maryland and its common stock trades on the New York Stock Exchange under the symbol NHI.
Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a conduit for external exhibits (Exhibit 99.1 and 99.2) containing the detailed financial data and investor presentation materials.
Material Changes
No material changes to financial performance or operations are detailed within the body of this Form 8-K. The filing references the attached exhibits for the substance of the investor update.
Guidance, Outlook, and Risks
Management commentary, guidance, and outlook are contained within the attached investor presentation (Exhibit 99.2) and press release (Exhibit 99.1), which are not included in the text of this filing. The filing explicitly states that the information in these exhibits is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial metrics and operational updates by accessing the attached Exhibit 99.1 (Press Release) and Exhibit 99.2 (Investor Presentation) on the company's website or the SEC EDGAR database.
- Note that the information in the exhibits is not legally "filed" for liability purposes under Section 18 of the Exchange Act.
- Confirm the date of the investor update is May 5, 2025.
- Identify John L. Spaid as the Principal Financial Officer who authorized the report.